CHOSA Oncology AB
Develops diagnostics and targeted therapies to personalize platinum-based cancer treatments.
CHOSA | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0007784319
- LEI:
- 5493002SFL9YXB0A0027
- Country:
- Sweden
- Address:
- C/O Medicon Village, C/O Medicon Village, Scheeletorget 1, 223 81 Lund
- Website:
- https://www.chosaoncology.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
CHOSA Oncology AB is a biotechnology company focused on advancing precision oncology. The company's core product is Platin-DRP®, a patented diagnostic test that analyzes a 205-gene signature from a patient's tumor to predict their response to platinum-based chemotherapies, including cisplatin and carboplatin. This technology enables personalized treatment strategies, aiming to improve survival rates and avoid unnecessary toxicity for non-responding patients. The company is also developing LiPlaCis®, a novel liposomal formulation of cisplatin designed for targeted drug delivery to tumors, thereby reducing systemic side effects. CHOSA's technologies are primarily aimed at cancers such as lung, breast, bladder, and endometrial.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all CHOSA Oncology AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for CHOSA Oncology AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
